
Pappas Capital
Description
Pappas Capital is a well-established venture capital firm specializing in the life sciences sector, founded in 1994 and based in Durham, North Carolina. The firm is dedicated to bridging the early-stage funding gap for innovative companies developing new products and technologies in biotechnology, pharmaceuticals, medical devices, and diagnostics. With a long-standing track record, Pappas Capital has successfully raised over $600 million in capital across five venture capital funds, demonstrating significant commitment to the life sciences ecosystem.
Investor Profile
Pappas Capital has backed more than 33 startups, with 3 new investments in the last 12 months alone. The firm has led 3 rounds, about 9% of its total and boasts 9 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, Singapore, Canada.
- Strong thematic focus on Biotechnology, Medical, Health Care.
- Typical check size: $1M – $5M.
Stage Focus
- Series A (42%)
- Series B (18%)
- Series Unknown (15%)
- Series C (12%)
- Series D (6%)
- Post Ipo Equity (6%)
Country Focus
- United States (76%)
- Singapore (12%)
- Canada (6%)
- China (6%)
Industry Focus
- Biotechnology
- Medical
- Health Care
- Pharmaceutical
- Therapeutics
- Software
- Life Science
- Medical Device
- Genetics
- Artificial Intelligence (Ai)
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.